Universal cell injection tested as new weapon against tough blood cancers
NCT ID NCT07131254
Summary
This early-stage study is testing a new, 'off-the-shelf' cell therapy called GT719 in adults with B-cell blood cancers (like certain leukemias and lymphomas) that have come back or not responded to other treatments. The main goals are to see if the treatment is safe, what side effects occur, and to get an early look at whether it helps control the cancer. Researchers will also track how long the infused cells last and behave in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ganzhou City People's Hospital
RECRUITINGGanzhou, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.